BioCryst Pharmaceuticals, Inc. (BCRX)
8.91
-0.19
(-2.09%)
USD |
NASDAQ |
May 29, 16:00
8.92
+0.01
(+0.11%)
After-Hours: 20:00
BioCryst Pharmaceuticals Market Cap : 2.265B for May 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Dyne Therapeutics, Inc. | 3.196B |
| Taysha Gene Therapies, Inc. | 1.687B |
| Agenus, Inc. | 145.75M |
| Amgen, Inc. | 181.77B |
| Anika Therapeutics, Inc. | 193.33M |
Market Cap Related Metrics
| PS Ratio | 2.267 |
| PEG Ratio | -0.0085 |
| Price to Free Cash Flow | 6.851 |
| Price | 8.91 |
| Earnings Yield | -19.94% |
| PEGY Ratio | -0.0085 |
| Operating PE Ratio | 6.355 |
| Normalized PE Ratio | 29.78 |